Ironwood Pharmaceuticals Current Ratio 2009-2019 | IRWD

Ironwood Pharmaceuticals current ratio from 2009 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Ironwood Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.26B $0.05B 4.88
2019-06-30 $0.22B $0.11B 1.99
2019-03-31 $0.20B $0.12B 1.70
2018-12-31 $0.27B $0.12B 2.23
2018-09-30 $0.25B $0.11B 2.21
2018-06-30 $0.28B $0.10B 2.94
2018-03-31 $0.28B $0.06B 4.42
2017-12-31 $0.31B $0.07B 4.72
2017-09-30 $0.31B $0.06B 4.87
2017-06-30 $0.34B $0.08B 4.27
2017-03-31 $0.36B $0.08B 4.54
2016-12-31 $0.38B $0.09B 4.17
2016-09-30 $0.38B $0.10B 4.02
2016-06-30 $0.39B $0.09B 4.24
2016-03-31 $0.50B $0.08B 6.35
2015-12-31 $0.50B $0.08B 6.54
2015-09-30 $0.51B $0.07B 7.46
2015-06-30 $0.53B $0.06B 8.49
2015-03-31 $0.26B $0.06B 4.41
2014-12-31 $0.29B $0.06B 4.76
2014-09-30 $0.30B $0.05B 5.63
2014-06-30 $0.33B $0.04B 7.83
2014-03-31 $0.37B $0.04B 9.64
2013-12-31 $0.23B $0.04B 5.58
2013-09-30 $0.28B $0.04B 6.95
2013-06-30 $0.34B $0.04B 7.64
2013-03-31 $0.28B $0.06B 4.40
2012-12-31 $0.18B $0.06B 3.36
2012-09-30 $0.20B $0.04B 5.69
2012-06-30 $0.17B $0.05B 3.38
2012-03-31 $0.21B $0.05B 3.95
2011-12-31 $0.17B $0.07B 2.57
2011-09-30 $0.18B $0.07B 2.52
2011-06-30 $0.21B $0.07B 2.94
2011-03-31 $0.23B $0.06B 3.78
2010-12-31 $0.26B $0.06B 4.02
2010-09-30 $0.26B $0.06B 4.71
2010-06-30 $0.28B $0.06B 4.93
2010-03-31 $0.31B $0.06B 5.57
2009-12-31 $0.13B $0.06B 2.33
2009-09-30 $0.12B $0.05B 2.30
2009-06-30 $0.00B 0.00
2009-03-31 $0.00B 0.00
2008-12-31 $0.11B $0.04B 2.87
2008-09-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.012B $0.347B
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation and chronic constipation. The Company also focuses on one Phase 1 pain drug candidate and multiple preclinical programs, as well as on building a specialty biochemicals business based on a proprietary strain-development platform. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.891B 39.41
Takeda Pharmaceutical (TAK) Japan $62.405B 9.86
Astellas Pharma (ALPMY) Japan $32.771B 16.37
Eisai (ESALY) Japan $21.953B 42.32
Merck (MKGAF) Germany $16.705B 22.80
Grifols, S.A (GRFS) Spain $15.965B 20.92
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Neurocrine Biosciences (NBIX) United States $9.410B 444.24
Catalent (CTLT) United States $9.008B 36.65
Ionis Pharmaceuticals (IONS) United States $8.496B 17.21
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.435B 10.77
IPSEN SA ADR (IPSEY) France $7.632B 0.00
STADA ARZNEIMI (STDAF) Germany $5.991B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.336B 16.23
Arrowhead Pharmaceuticals (ARWR) United States $4.423B 66.97
Evotec AG (EVTCY) Germany $4.301B 69.51
United Therapeutics (UTHR) United States $3.988B 0.00
FibroGen (FGEN) United States $3.853B 113.23
Nektar Therapeutics (NKTR) United States $3.830B 0.00
Sage Therapeutics (SAGE) United States $3.651B 0.00
PTC Therapeutics (PTCT) United States $3.287B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.239B 11.92
Zogenix (ZGNX) United States $2.404B 0.00
ChemoCentryx (CCXI) United States $2.365B 0.00
Tilray (TLRY) Canada $2.128B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.128B 0.00
Heron Therapeutics (HRTX) United States $2.107B 0.00
Xencor (XNCR) United States $2.043B 62.09
Pacira Pharmaceuticals (PCRX) United States $1.834B 54.25
USANA Health Sciences (USNA) United States $1.659B 17.70
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.522B 10.39
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Corcept Therapeutics (CORT) United States $1.501B 18.24
Endo (ENDP) Ireland $1.496B 2.75
Theravance Biopharma (TBPH) Cayman Islands $1.468B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.109B 25.23
Karyopharm Therapeutics (KPTI) United States $1.089B 0.00
Portola Pharmaceuticals (PTLA) United States $1.070B 0.00
Aerie Pharmaceuticals (AERI) United States $1.045B 0.00
Dermira (DERM) United States $1.023B 0.00
Akebia Therapeutics (AKBA) United States $1.019B 0.00
Radius Health (RDUS) United States $0.873B 0.00
ImmunoGen (IMGN) United States $0.734B 0.00
Collegium Pharmaceutical (COLL) United States $0.710B 0.00
TherapeuticsMD (TXMD) United States $0.694B 0.00
Flexion Therapeutics (FLXN) United States $0.687B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.553B 0.00
Molecular Templates (MTEM) United States $0.531B 0.00
Translate Bio (TBIO) United States $0.522B 0.00
Ardelyx (ARDX) United States $0.475B 0.00
Organogenesis Holdings (ORGO) United States $0.470B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.454B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.445B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.444B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.433B 52.50
Innate Pharma SA (IPHYF) France $0.432B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.431B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.427B 18.40
Siga Technologies (SIGA) United States $0.422B 9.65
DURECT (DRRX) United States $0.404B 0.00
Lannett Co Inc (LCI) United States $0.395B 4.60
OptiNose (OPTN) United States $0.371B 0.00
Calithera Biosciences (CALA) United States $0.371B 0.00
Harpoon Therapeutics (HARP) United States $0.369B 0.00
Recro Pharma (REPH) United States $0.369B 0.00
Rafael Holdings (RFL) United States $0.356B 0.00
Indivior (INVVY) United States $0.339B 1.23
Spectrum Pharmaceuticals (SPPI) United States $0.324B 0.00
KalVista Pharmaceuticals (KALV) United States $0.322B 0.00
Concert Pharmaceuticals (CNCE) United States $0.304B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.282B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.261B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.246B 0.00
MEI Pharma (MEIP) United States $0.239B 0.00
Ocular Therapeutix (OCUL) United States $0.225B 0.00
IMV INC (IMV) Canada $0.222B 0.00
Jounce Therapeutics (JNCE) United States $0.217B 2.90
La Jolla Pharmaceutical (LJPC) United States $0.209B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 32.83
Taiwan Liposome (TLC) Taiwan $0.171B 0.00
Xeris Pharmaceuticals (XERS) United States $0.163B 0.00
CannTrust Holdings (CTST) Canada $0.157B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.143B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.136B 0.00
Redhill Biopharma (RDHL) Israel $0.130B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.128B 0.00
CV Sciences (CVSI) United States $0.117B 0.00
Otonomy (OTIC) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.107B 0.00
PolarityTE (PTE) United States $0.106B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.099B 0.00
Champions Oncology (CSBR) United States $0.099B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.094B 0.00
Neos Therapeutics (NEOS) United States $0.087B 0.00
Infinity Pharmaceuticals (INFI) United States $0.087B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 22.82
RENEURON GP (RNUGF) United Kingdom $0.074B 0.00
CTI BioPharma (CTIC) United States $0.073B 0.00
AgeX Therapeutics (AGE) United States $0.070B 0.00
Aclaris Therapeutics (ACRS) United States $0.066B 0.00
Natural Alternatives (NAII) United States $0.066B 16.49
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
Nivalis Therapeutics (ALPN) United States $0.060B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
IsoRay (ISR) United States $0.057B 0.00
Onconova Therapeutics (ONTX) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
Jaguar Animal Health (JAGX) United States $0.041B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
VAXART, INC (VXRT) United States $0.025B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.018B 0.00
Novan (NOVN) United States $0.018B 0.00
Shineco (TYHT) China $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Lipocine (LPCN) United States $0.013B 0.00
Flex Pharma (SLRX) United States $0.013B 0.00
Vical (BBI) United States $0.012B 0.00
Heat Biologics (HTBX) United States $0.011B 0.00
Hemispherx BioPharma (AIM) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00